Pharmena S.A. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was PLN 8.32 million compared to PLN 6.78 million a year ago. Net loss was PLN 0.633 million compared to PLN 2.49 million a year ago.

Basic loss per share from continuing operations was PLN 0.06 compared to PLN 0.22 a year ago. Diluted loss per share from continuing operations was PLN 0.06 compared to PLN 0.22 a year ago.